Q2 Earnings Forecast for CMPX Issued By Leerink Partnrs
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Stock analysts at Leerink Partnrs dropped their Q2 2025 EPS estimates for shares of Compass Therapeutics in a research note issued on Tuesday, April 1st. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings per share of ($0.17) for the quarter, down from […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Stock analysts at Leerink Partnrs dropped their Q2 2025 EPS estimates for shares of Compass Therapeutics in a research note issued on Tuesday, April 1st. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings per share of ($0.17) for the quarter, down from […]
